Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome

By Yamamoto Wataru   Ogusa Eriko   Matsumoto Kenji   Maruta Atsuo   Ishigatsubo Yoshiaki   Kanamori Heiwa  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1113-1118

Informa Healthcare

Access to resources Recommend Favorite

Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia

By Devillier Raynier   Crocchiolo Roberto   Etienne Anne   Prebet Thomas   Charbonnier Aude   Fürst Sabine   El-Cheikh Jean   D'Incan Evelyne   Rey Jérôme   Faucher Catherine   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1228-1234

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal AA amyloidosis following allogeneic hematopoietic stem cell transplant in a patient with chronic myelogenous leukemia

By Honda Akira  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1794-1796

Informa Healthcare

Access to resources Recommend Favorite

Pre-transplant serum ferritin is prognostic but is it useful?

By Artz Andrew S.  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1133-1134

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

By Prebet Thomas   Charbonnier Aude   Gelsi-Boyer Véronique   Mozziconacci Marie Joelle   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1538-1540

Informa Healthcare

Access to resources Recommend Favorite